New vaginal ring could make preterm birth prevention easier
NCT ID NCT06668896
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage study tests a new progesterone vaginal ring (8mg or 12mg daily) against a standard progesterone insert (100mg) in 60 healthy postmenopausal women. Researchers will measure how much progesterone gets into the blood over 14 days. The goal is to see if the ring delivers the hormone effectively, which could later be tested to prevent preterm birth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- progesterone
- What this could lead to
- If successful, this could lead to a more convenient progesterone delivery method to help prevent preterm birth.
- What could go wrong
- This is a very early Phase 1 study in healthy volunteers, not pregnant women. It only measures drug levels, not whether the ring prevents preterm birth. Many early-stage trials do not lead to approved treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-TERM BIRTH are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.